Successful Treatment of Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck Using Pembrolizumab

Opuholi Golovy i Sei - Russian Federation
doi 10.17650/2222-1468-2019-9-1-93-98
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House ABV Press

Related search

Nimotuzumab Plus Radiotherapy for Unresectable Squamous-Cell Carcinoma of the Head and Neck

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Profile of Pembrolizumab in the Treatment of Head and Neck Squamous Cell Carcinoma: Design Development and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma: Incidence, Survival, Prognostic Factors, and Treatment Outcomes

Oncotarget
Oncology
2017English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy